Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from SSY Group ( (HK:2005) ) is now available.
SSY Group Limited faced a challenging business environment in 2024, marked by sluggish economic recovery and intensified trade protectionism. Despite these challenges, the company maintained stable development by focusing on innovation and optimizing its product mix. The company reported a revenue of approximately HK$5,773 million, a decrease of 10.7% from the previous year, and a net profit of HK$1,061 million, down by 19.5%. The company declared a final dividend of HK$0.095 per share, with a total dividend for the year increasing by 2.9%.
More about SSY Group
SSY Group Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the production and sale of pharmaceutical products, including intravenous infusion solutions, bulk pharmaceuticals, and medical materials.
YTD Price Performance: -1.40%
Technical Sentiment Signal: Buy
Current Market Cap: $1.27B
Learn more about 2005 stock on TipRanks’ Stock Analysis page.